Skip to content

There’s always more to discover with an AARP membership! Check out your member benefits.


FDA Urges Reduced Doses for Anemia Drugs

According to U.S. health officials, doctors should use the anemia drugs Procrit, Epogen and Aranesp more cautiously in patients with chronic kidney disease.

The new warning comes in response to data showing that patients on these drugs face a higher risk of cardiovascular problems such as heart attack, heart failure, stroke, blood clots and death. Read

See also: 7 Simple Steps for Heart Health

Join the Discussion

0 | Add Yours

Please leave your comment below.

You must be logged in to leave a comment.